Cargando…
Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease
Background: Elevated progranulin levels are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. Progranulin has not been previously investigated as a biomarker of nonalcoholic fatty liver disease (NAFLD). We sought to determine whether serum progranulin levels are altered in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826876/ https://www.ncbi.nlm.nih.gov/pubmed/22045426 http://dx.doi.org/10.3233/DMA-2011-0815 |
_version_ | 1782290974042488832 |
---|---|
author | Yilmaz, Yusuf Eren, Fatih Yonal, Oya Polat, Zulfikar Bacha, Mohammad Kurt, Ramazan Ozturk, Oguzhan Avsar, Erol |
author_facet | Yilmaz, Yusuf Eren, Fatih Yonal, Oya Polat, Zulfikar Bacha, Mohammad Kurt, Ramazan Ozturk, Oguzhan Avsar, Erol |
author_sort | Yilmaz, Yusuf |
collection | PubMed |
description | Background: Elevated progranulin levels are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. Progranulin has not been previously investigated as a biomarker of nonalcoholic fatty liver disease (NAFLD). We sought to determine whether serum progranulin levels are altered in patients with biopsy-proven NAFLD and if they are associated with their clinical, biochemical, and histological characteristics. Subjects and methods: We measured serum progranulin levels in 95 patients with biopsy-proven NAFLD and 80 age- and sex-matched controls. The potential associations between progranulin and the characteristics of NAFLD patients were examined by multiple linear regression analysis. Results: Serum progranulin levels were significantly higher in NAFLD patients (34 ± 13 ng/mL) than in controls (28 ± 7 ng/mL, P < 0.001). In NAFLD patients, serum progranulin levels were associated with lipid levels and the degree of hepatic fibrosis. After adjustment for potential confounders, serum progranulin remained an independent predictor of the degree of hepatic fibrosis in NAFLD patients (β = 0.392; t =2.226, P < 0.01). Conclusions: Compared with controls, NAFLD patients have higher serum progranulin concentrations, which are closely associated with lipid values and the extent of hepatic fibrosis. |
format | Online Article Text |
id | pubmed-3826876 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | IOS Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-38268762013-12-01 Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease Yilmaz, Yusuf Eren, Fatih Yonal, Oya Polat, Zulfikar Bacha, Mohammad Kurt, Ramazan Ozturk, Oguzhan Avsar, Erol Dis Markers Other Background: Elevated progranulin levels are associated with visceral obesity, elevated plasma glucose, and dyslipidemia. Progranulin has not been previously investigated as a biomarker of nonalcoholic fatty liver disease (NAFLD). We sought to determine whether serum progranulin levels are altered in patients with biopsy-proven NAFLD and if they are associated with their clinical, biochemical, and histological characteristics. Subjects and methods: We measured serum progranulin levels in 95 patients with biopsy-proven NAFLD and 80 age- and sex-matched controls. The potential associations between progranulin and the characteristics of NAFLD patients were examined by multiple linear regression analysis. Results: Serum progranulin levels were significantly higher in NAFLD patients (34 ± 13 ng/mL) than in controls (28 ± 7 ng/mL, P < 0.001). In NAFLD patients, serum progranulin levels were associated with lipid levels and the degree of hepatic fibrosis. After adjustment for potential confounders, serum progranulin remained an independent predictor of the degree of hepatic fibrosis in NAFLD patients (β = 0.392; t =2.226, P < 0.01). Conclusions: Compared with controls, NAFLD patients have higher serum progranulin concentrations, which are closely associated with lipid values and the extent of hepatic fibrosis. IOS Press 2011 2011-11-01 /pmc/articles/PMC3826876/ /pubmed/22045426 http://dx.doi.org/10.3233/DMA-2011-0815 Text en Copyright © 2011 Hindawi Publishing Corporation. |
spellingShingle | Other Yilmaz, Yusuf Eren, Fatih Yonal, Oya Polat, Zulfikar Bacha, Mohammad Kurt, Ramazan Ozturk, Oguzhan Avsar, Erol Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease |
title | Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease |
title_full | Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease |
title_fullStr | Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease |
title_full_unstemmed | Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease |
title_short | Serum Progranulin as an Independent Marker of Liver Fibrosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease |
title_sort | serum progranulin as an independent marker of liver fibrosis in patients with biopsy-proven nonalcoholic fatty liver disease |
topic | Other |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826876/ https://www.ncbi.nlm.nih.gov/pubmed/22045426 http://dx.doi.org/10.3233/DMA-2011-0815 |
work_keys_str_mv | AT yilmazyusuf serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease AT erenfatih serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease AT yonaloya serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease AT polatzulfikar serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease AT bachamohammad serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease AT kurtramazan serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease AT ozturkoguzhan serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease AT avsarerol serumprogranulinasanindependentmarkerofliverfibrosisinpatientswithbiopsyprovennonalcoholicfattyliverdisease |